203 related articles for article (PubMed ID: 37138385)
1. Pre-treatment bicarbonate levels and decongestion by acetazolamide: the ADVOR trial.
Martens P; Verbrugge FH; Dauw J; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Heylen L; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
Eur Heart J; 2023 Jun; 44(22):1995-2005. PubMed ID: 37138385
[TBL] [Abstract][Full Text] [Related]
2. Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial.
Martens P; Dauw J; Verbrugge FH; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
Circulation; 2023 Jan; 147(3):201-211. PubMed ID: 36335479
[TBL] [Abstract][Full Text] [Related]
3. Sodium and potassium changes during decongestion with acetazolamide - A pre-specified analysis from the ADVOR trial.
Dhont S; Martens P; Meekers E; Dauw J; Verbrugge FH; Nijst P; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
Eur J Heart Fail; 2023 Aug; 25(8):1310-1319. PubMed ID: 37062871
[TBL] [Abstract][Full Text] [Related]
4. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
Mullens W; Dauw J; Martens P; Verbrugge FH; Nijst P; Meekers E; Tartaglia K; Chenot F; Moubayed S; Dierckx R; Blouard P; Troisfontaines P; Derthoo D; Smolders W; Bruckers L; Droogne W; Ter Maaten JM; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M;
N Engl J Med; 2022 Sep; 387(13):1185-1195. PubMed ID: 36027559
[TBL] [Abstract][Full Text] [Related]
5. Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.
Mullens W; Dauw J; Martens P; Meekers E; Nijst P; Verbrugge FH; Chenot F; Moubayed S; Dierckx R; Blouard P; Derthoo D; Smolders W; Ector B; Hulselmans M; Lochy S; Raes D; Van Craenenbroeck E; Vandekerckhove H; Hofkens PJ; Goossens K; Pouleur AC; De Ceuninck M; Gabriel L; Timmermans P; Prihadi EA; Van Durme F; Depauw M; Vervloet D; Viaene E; Vachiery JL; Tartaglia K; Ter Maaten JM; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
Eur J Heart Fail; 2022 Sep; 24(9):1601-1610. PubMed ID: 35733283
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial.
Mullens W; Verbrugge FH; Nijst P; Martens P; Tartaglia K; Theunissen E; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
Eur J Heart Fail; 2018 Nov; 20(11):1591-1600. PubMed ID: 30238574
[TBL] [Abstract][Full Text] [Related]
7. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload.
Verbrugge FH; Martens P; Dauw J; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Damman K; Filippatos G; Lassus J; Mebazaa A; Ruschitzka F; Dupont M; Mullens W
J Am Coll Cardiol; 2023 May; 81(20):2013-2024. PubMed ID: 37197845
[TBL] [Abstract][Full Text] [Related]
9. Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial.
Meekers E; Dauw J; Martens P; Dhont S; Verbrugge FH; Nijst P; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
Eur Heart J; 2023 Oct; 44(37):3672-3682. PubMed ID: 37623428
[TBL] [Abstract][Full Text] [Related]
10. Similarities and distinctions between acetazolamide and sodium-glucose cotransporter 2 inhibitors in patients with acute heart failure: Key insights into ADVOR and EMPULSE.
Packer M; Butler J
Eur J Heart Fail; 2023 Sep; 25(9):1537-1543. PubMed ID: 37403655
[TBL] [Abstract][Full Text] [Related]
11. Considering Addition of Acetazolamide to Loop Diuretics as Treatment for Acute Heart Failure: ADVOR Reappraisal.
Greene SJ; Felker GM
JACC Heart Fail; 2023 Mar; 11(3):365-367. PubMed ID: 36889884
[No Abstract] [Full Text] [Related]
12. [Combination diuretic therapy in heart failure].
Massop K; Kramers CK
Ned Tijdschr Geneeskd; 2023 May; 167():. PubMed ID: 37257097
[TBL] [Abstract][Full Text] [Related]
13. Tackling Congestion in Acute Heart Failure: Is It the Primetime for "Combo Diuretic Therapy?".
Kazory A; Ronco C
Cardiorenal Med; 2023; 13(1):184-188. PubMed ID: 36787714
[TBL] [Abstract][Full Text] [Related]
14. Assessing intrinsic renal sodium avidity in acute heart failure: implications in predicting and guiding decongestion.
Martens P; Chen HH; Verbrugge FH; Testani JT; Mullens W; Tang WHW
Eur J Heart Fail; 2022 Oct; 24(10):1978-1987. PubMed ID: 36054180
[TBL] [Abstract][Full Text] [Related]
15. Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload.
Verbrugge FH; Dupont M; Bertrand PB; Nijst P; Penders J; Dens J; Verhaert D; Vandervoort P; Tang WH; Mullens W
Acta Cardiol; 2015 Jun; 70(3):265-73. PubMed ID: 26226699
[TBL] [Abstract][Full Text] [Related]
16. In acute decompensated HF, adding acetazolamide to IV loop diuretics reduced congestion at 3 d across eGFR levels.
Rospert D; Molony DA
Ann Intern Med; 2024 Jan; 177(1):JC2. PubMed ID: 38163366
[TBL] [Abstract][Full Text] [Related]
17. Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study.
Dauw J; Lelonek M; Zegri-Reiriz I; Paredes-Paucar CP; Zara C; George V; Cobo-Marcos M; Knappe D; Shchekochikhin D; Lekhakul A; Klincheva M; Frea S; Miró Ò; Barker D; Borbély A; Nasr S; Doghmi N; de la Espriella R; Singh JS; Bovolo V; Fialho I; Ross NT; van den Heuvel M; Benkouar R; Findeisen H; Alhaddad IA; Al Balbissi K; Barge-Caballero G; Ghazi AM; Bruckers L; Martens P; Mullens W
ESC Heart Fail; 2021 Dec; 8(6):4685-4692. PubMed ID: 34708555
[TBL] [Abstract][Full Text] [Related]
18. A new role for an old drug: acetazolamide in decompensated heart failure.
Doggrell SA
Expert Opin Pharmacother; 2023 Feb; 24(3):309-313. PubMed ID: 36562420
[TBL] [Abstract][Full Text] [Related]
19. Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study.
Dauw J; Charaya K; Lelonek M; Zegri-Reiriz I; Nasr S; Paredes-Paucar CP; Borbély A; Erdal F; Benkouar R; Cobo-Marcos M; Barge-Caballero G; George V; Zara C; Ross NT; Barker D; Lekhakul A; Frea S; Ghazi AM; Knappe D; Doghmi N; Klincheva M; Fialho I; Bovolo V; Findeisen H; Alhaddad IA; Galluzzo A; de la Espriella R; Tabbalat R; Miró Ò; Singh JS; Nijst P; Dupont M; Martens P; Mullens W
Circ Heart Fail; 2024 Jan; 17(1):e011105. PubMed ID: 38179728
[TBL] [Abstract][Full Text] [Related]
20. Diuretic, natriuretic, and chloride-regaining effects of oral acetazolamide as an add-on therapy for acute heart failure with volume overload: a single-center, prospective, randomized study.
Kosiorek A; Urban S; Detyna J; Biegus J; Hurkacz M; Zymliński R
Pol Arch Intern Med; 2023 Dec; 133(12):. PubMed ID: 37415505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
